Predictive tools for severe dengue conforming to World Health Organization 2009 criteria
- PMID: 25010515
- PMCID: PMC4091876
- DOI: 10.1371/journal.pntd.0002972
Predictive tools for severe dengue conforming to World Health Organization 2009 criteria
Abstract
Background: Dengue causes 50 million infections per year, posing a large disease and economic burden in tropical and subtropical regions. Only a proportion of dengue cases require hospitalization, and predictive tools to triage dengue patients at greater risk of complications may optimize usage of limited healthcare resources. For severe dengue (SD), proposed by the World Health Organization (WHO) 2009 dengue guidelines, predictive tools are lacking.
Methods: We undertook a retrospective study of adult dengue patients in Tan Tock Seng Hospital, Singapore, from 2006 to 2008. Demographic, clinical and laboratory variables at presentation from dengue polymerase chain reaction-positive and serology-positive patients were used to predict the development of SD after hospitalization using generalized linear models (GLMs).
Principal findings: Predictive tools compatible with well-resourced and resource-limited settings--not requiring laboratory measurements--performed acceptably with optimism-corrected specificities of 29% and 27% respectively for 90% sensitivity. Higher risk of severe dengue (SD) was associated with female gender, lower than normal hematocrit level, abdominal distension, vomiting and fever on admission. Lower risk of SD was associated with more years of age (in a cohort with an interquartile range of 27-47 years of age), leucopenia and fever duration on admission. Among the warning signs proposed by WHO 2009, we found support for abdominal pain or tenderness and vomiting as predictors of combined forms of SD.
Conclusions: The application of these predictive tools in the clinical setting may reduce unnecessary admissions by 19% allowing the allocation of scarce public health resources to patients according to the severity of outcomes.
Conflict of interest statement
VJL has received unrelated research grants from GlaxoSmithKline. The rest of the authors declare no conflict of interest. This does not alter our adherence to all PLOS policies on sharing data and materials.
Figures
References
-
- Gubler DJ, Meltzer M (1999) Impact of dengue/dengue hemorrhagic fever on the developing world. In: Karl Margniorosch FAM, Aaron JS, editors. Advances in Virus Research: Academic Press. pp. 35–70. - PubMed
-
- Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology 10: 100–103. - PubMed
-
- Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, et al. (2009) Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. American Journal of Tropical Medicine and Hygiene 80: 846–855. - PubMed
-
- Halstead SB (2007) Dengue. The Lancet 370: 1644–1652. - PubMed
-
- WHO (2002) Weekly epidemiological record. World Health Organization. Available: http://www.who.int/docstore/wer/pdf/2002/wer7736.pdf. Accessed 2011 Nov 4.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
